Skip to content
  • Rheuma Pics Hub
  • Rheuma Calculator
  • Books
  • Account
  • Dashboard
  • Login
  • Logout
  • Register
  • Rheuma Tv in 2024
Rheuma Tv
  • Home
  • Student Corner
    • PG Section
    • UG Section
  • Case Discussion
  • Research
    • Journal Club
  • Webinar
    • Live Webinar
      • Biologics in AIRD
      • AIRD and INFLAMMATION
      • SLE and Inflammation
      • Immunology and Inflammation
      • Eye and Rheumatology Series
      • Investigation in Rheumatology
      • Expert Talk
      • Tofacitinib in Rheumatology
      • CS DMARDS in RA
    • Past Webinar
    • Webinar Registration
  • News and Views
  • Conference
    • ChanRe Update 2024
    • ChanRe Update 2023
    • ChanRe Update 2022
    • ChanRe Update 2021
    • SIRCON 2023
    • Karnataka Vasculitis Club
  • Quiz
  • Courses

Rheuma Tv

Mavrilimumab may be a potential treatment for giant cell arteritis

March 21, 2022March 21, 2022

Translational study findings have corroborated the role of granulocyte-macrophage colony-stimulating factor (GM-CSF) in upregulating TH1/TH17 pathways and pathogenesis in temporal arteries of patients with giant …

Read more

The effect of baricitinib in uncoupling the disease activity and structural damage progression in RA

March 22, 2022March 21, 2022

Janus kinase inhibitor, baricitinib, is found to be beneficial in enhancing disease-modifying effects in patients with rheumatoid arthritis, according to the findings published in Annals of …

Read more

Experts highlight myositis-specific and associated autoantibody (MSA/MAA) testing in diagnosing idiopathic inflammatory myopathy

March 17, 2022
idiopathic inflammatory myopathy

A study published in the Journal of Translational Autoimmunity by experts has acknowledged the need for identification of myositis-specific antibodies (MSA) and myositis-associated antibodies (MAA) …

Read more

Etanercept tapering is feasible without compromising the efficacy in patients with autoimmune disease

March 14, 2022

Etanercept, a soluble recombinant tumor necrosis factor (TNF) receptor fusion protein, is indicated for the treatment of rheumatoid arthritis (RA), psoriatic arthritis, and ankylosing spondylitis. …

Read more

Anti–IL-1 receptor antagonist autoantibodies stimulate inflammatory and fibrotic mediators in IgG4-related disease

March 11, 2022

A new study published in the journal of allergy and clinical immunology has reported that anti-interleukin-1 receptor antagonist (IL-1RA) autoantibodies in patients with IgG4-RD can …

Read more

Safety concerns, precautions and management of adverse events by Dr.Chandrashekara.S, Bengaluru

July 15, 2024March 11, 2022

Dr. Chandrashekara. S discussed the precautions before administration of tofacitinib. Jak inhibitors are Pan cytokines blocker that impairs the immune system functioning effectively. Incidence of …

Read more

Tofacitinib_indications & its use in Rheumatolgy by Dr. Raj Kiran, Hyderabad

July 15, 2024March 11, 2022

  Dr. Rajkiran Dudam spoke about the tofacitinib indications and their use in rheumatology. Tofacitinib comes with lots of expectations and its generics are widely …

Read more

JAK Inhibitor_ a concept to utility in the management of Autoimmune Disease by Dr. Puja Srivastava

July 15, 2024March 11, 2022

Dr. Puja Srivastava discussed the concept of JAK inhibitor utility in the management of autoimmune diseases. Activation of the JAK-STAT Signal transduction pathway is a …

Read more

Researchers explore the pattern of uveitis in routine ophthalmology practice in India

March 9, 2022

A recent retrospective study carried out in an ophthalmology clinic in north Karnataka has noted that anterior uveitis of noninfectious etiology is more frequent in …

Read more

Older posts
Newer posts
← Previous Page1 … Page26 Page27 Page28 … Page39 Next →

Important Links

  • Privacy Policy
  • Contact Us
  • Disclaimer
  • About Us
  • Terms and Conditions
  • Cancellation Policy
  • Refund Policy
  • Partner With Us

Disclaimer

This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. @2020 ChanRe Healthcare & Research Pvt Ltd.

Copyright © 2025 DMCA.com Protection Status
  • Home
  • Student Corner
    • PG Section
    • UG Section
  • Case Discussion
  • Research
    • Journal Club
  • Webinar
    • Live Webinar
      • Biologics in AIRD
      • AIRD and INFLAMMATION
      • SLE and Inflammation
      • Immunology and Inflammation
      • Eye and Rheumatology Series
      • Investigation in Rheumatology
      • Expert Talk
      • Tofacitinib in Rheumatology
      • CS DMARDS in RA
    • Past Webinar
    • Webinar Registration
  • News and Views
  • Conference
    • ChanRe Update 2024
    • ChanRe Update 2023
    • ChanRe Update 2022
    • ChanRe Update 2021
    • SIRCON 2023
    • Karnataka Vasculitis Club
  • Quiz
  • Courses